Raloxifene and breast cancer risk reduction based on breast cancer family history

被引：0
|
作者：
Martino, S [1 ]
Disch, D [1 ]
Dowsett, S [1 ]
Mershon, J [1 ]
机构：
[1] John Wayne Canc Inst, Santa Monica, CA USA
来源：
OBSTETRICS AND GYNECOLOGY | 2005年 / 105卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：4S / 5S
页数：2
相关论文
共 50 条
  • [31] Raloxifene and the risk of breast cancer, heart disease
    Ebell, Mark
    AMERICAN FAMILY PHYSICIAN, 2006, 74 (09) : 1598 - +
  • [32] Raloxifene and breast cancer
    Lorraine, J
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2001, 165 (07) : 888 - 888
  • [33] Raloxifene reduces breast-cancer risk
    Husten, L
    LANCET, 1999, 353 (9146): : 44 - 44
  • [34] Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
    Vogel, Victor G.
    CLINICAL INTERVENTIONS IN AGING, 2008, 3 (04): : 601 - 609
  • [35] Family history of breast and ovarian cancer and the risk of breast carcinoma in situ
    Claus, EB
    Stowe, M
    Carter, D
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 78 (01) : 7 - 15
  • [36] Family History of Breast and Ovarian Cancer and the Risk of Breast Carcinoma in situ
    Elizabeth B. Claus
    Meredith Stowe
    Darryl Carter
    Breast Cancer Research and Treatment, 2003, 78 : 7 - 15
  • [37] A family affair: Prostate cancer risk and family history of breast or prostate cancer
    Barber, Lauren E.
    Gerke, Travis A.
    Markt, Sarah C.
    Parmigiani, Giovanni
    Mucci, Lorelei A.
    CANCER RESEARCH, 2016, 76
  • [38] Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History
    van den Broek, Jeroen J.
    Schechter, Clyde B.
    van Ravesteyn, Nicolien T.
    Janssens, A. Cecile J. W.
    Wolfson, Michael C.
    Trentham-Dietz, Amy
    Simard, Jacques
    Easton, Douglas F.
    Mandelblatt, Jeanne S.
    Kraft, Peter
    de Koning, Harry J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (04): : 434 - 442
  • [39] The raloxifene plus zoladex (RAZOR) trial for breast cancer risk reduction.
    Eccles, DM
    Dowsett, M
    Howell, A
    Evans, G
    Chapman, K
    Eeles, R
    Mackay, J
    Fallowfield, L
    Cuzick, J
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1194S - 1194S
  • [40] Family History, Mammographic Density, and Risk of Breast Cancer
    Martin, Lisa J.
    Melnichouk, Olga
    Guo, Helen
    Chiarelli, Anna M.
    Hislop, T. Gregory
    Yaffe, Martin J.
    Minkin, Salomon
    Hopper, John L.
    Boyd, Norman F.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (02) : 456 - 463
12345